المؤلفون: Anthony Sebba, Kimme L. Hyrich, N. Schlesinger, Juan J. Scali, Andrea Rubbert-Roth, A. Pikhlak, R. Cartwright, Deborah P M Symmons, E. Weisbarth-Riedel, K Chakravarty, B. Bodalia, E. Incera, I. Kone-Paut, Darren M. Ashcroft, A. E. Yücel, Sarah Mapplebeck, R. Preiss, Katalin Dankó, David A. Isenberg, Patrick Gordon, Alexander So, M. Gattorno, Moetaza M. Soliman, John B Winer, U. Arulmani, Bryan Lecky, V. Murphy, G. Krammer, P. Quartier, K. Leslie, E. Ramos, E. Hachulla, Kath D. Watson, F. Zulian, Ernest Choy, George D. Kitas, Dimitrios Christidis, David Scott, I. Foeldvari, Bhaskar Dasgupta, Mark Lunt, Ronald F van Vollenhoven, D. Richard, Beverley White-Alao, J. Hoyer, M. De Meulemeester, H. J. Lachmann, L. Lepore, J. Kerrane, P. N. Hawkins, Nada Hassan, Emma Vernon, Anna Kowalczyk, Fowzia Ibrahim, Moshe Zilberstein, Robert G. Cooper, Alan Hakim, Mark C. Genovese, P. Sallstig, Bridget Griffiths, J. B. Kuemmerle-Deschner

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Tumor necrosis factors, business.industry, Rheumatic disease, Physical function, medicine.disease, Rheumatology, Antirheumatic Agents, Patient Self-Report, Rheumatoid arthritis, Internal medicine, medicine, Physical therapy, Pharmacology (medical), Rituximab, business, skin and connective tissue diseases, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3c5b182b2ef00bc565dc0e13bf4cf7
http://doc.rero.ch/record/300341/files/ker073.pdf